On Monday, in the course of current trade, Shares of Yahoo! Inc. (NASDAQ:YHOO), climbed 2.06%, and is now trading at $129.78.
Yahoo Inc., declared the new Yahoo Sports Daily Fantasy — one-day and one-week fantasy contests for cash prizes. For nearly two decades, Yahoo Sports has entertained fans around the world with the most engaging content, news and fantasy experiences. Recently, we’re taking the game to the next level and giving fans what they’ve always wanted — the chance to compete with their friends and win cash, everyday. With today’s launch, Yahoo becomes the first major sports site and the only technology company of its scale to offer its own Daily Fantasy experience.
“For more than 16 years, we’ve built the best fantasy experience for our fans. Our users spend nearly 30 billion minutes a year playing fantasy sports on Yahoo, and recently we’re thrilled to introduce a daily fantasy experience designed for the modern fan,” said Simon Khalaf, SVP Product and Engineering at Yahoo. “The growing popularity of Daily Fantasy games is a fantastic opportunity for us to bolster our leadership by providing our millions of existing fantasy users as well new fans out there with a unique take on this game genre.”
Yahoo! Inc. provides search and display advertising services on Yahoo properties and associate sites worldwide. The company offers Yahoo Search that serves as a starting point to navigate the Internet and discover information; and Yahoo Answers, which enables users to seek, discover, and share knowledge and opinions across mobile phones, tablets, and desktops.
During an Afternoon trade, Shares of Fifth Street Finance Corp. (NASDAQ:FSC), dipped -0.31%, and is now trading at $6.52.
Fifth Street Finance Corp., declared that the Boards of Directors for both FSC and FSFR have promoted Steven M. Noreika to Chief Financial Officer, replacing Richard A. Petrocelli, who will be leaving Fifth Street to pursue other opportunities effective July 10, 2015. We would like to thank Rich for his contributions during his tenure and wish him success in his future endeavors. Alexander C. Frank remains Chief Financial Officer of Fifth Street Asset Administration Inc. (FSAM) (“FSAM”), the parent company of FSC and FSFR’s investment adviser.
Preceding to his promotion, Mr. Noreika has been serving as the Chief Accounting Officer of FSAM. Mr. Noreika joined Fifth Street in September 2008 and during his tenure, he has held various finance and accounting positions, counting Chief Financial Officer of FSFR from November 2013 to July 2014. Preceding to joining Fifth Street, Mr. Noreika spent six years at Time Warner Inc., where he was a manager of internal reporting, and preceding to that he managed audit and tax engagements at Marcum & Kliegman, LLP (now Marcum LLP). Mr. Noreika is a Certified Public Accountant and holds a B.B.A in Accounting from Pace University. He is also a holder of the Chartered Financial Analyst designation.
Finally, The Medicines Company (NASDAQ:MDCO), gained 1.99% Monday.
Medicines Company, planned its quarterly conference call for Wednesday, July 29th at 8:30 a.m. Eastern Time to talk about second quarter financial results, operational developments and outlook for 2015.
The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
